Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA
Marco Pérez(Instituto de Salud Carlos III), Amancio Carnero(Instituto de Salud Carlos III)
Cited by 62
Related Papers
Glycolytic Enzymes Can Modulate Cellular Life Span
|Cancer Research|2005|640
The cancer stem-cell signaling network and resistance to therapy
|Cancer Treatment Reviews|2016|155
Role of Mitochondria in Cancer Stem Cell Resistance
|Cells|2020|110
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
|Frontiers in Oncology|2020|67
The essential role of PIM kinases in sarcoma growth and bone invasion
|Carcinogenesis|2012|37